Salvage radiotherapy after prostatectomy - what is the best time to treat?

[1]  L. Kiemeney,et al.  Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  C. Perneel,et al.  A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  T. Wiegel,et al.  The German S3 Guideline Prostate Cancer , 2010, Strahlentherapie und Onkologie.

[4]  T. Henkel,et al.  Strahlentherapie des Prostatakarzinoms in der neuen S3-Leitlinie , 2010, Der Urologe.

[5]  T. Wiegel,et al.  Second Malignancies in High‑Dose Areas of Previous Tumor Radiotherapy , 2010, Strahlentherapie und Onkologie.

[6]  T. Henkel,et al.  Strahlentherapie des Prostatakarzinoms in der neuen S3-Leitlinie , 2010, Der Urologe.

[7]  M. Heckman,et al.  Late toxicity after postprostatectomy salvage radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  T. Wiegel,et al.  Postoperative Radiotherapy for Advanced Prostate Cancer , 2009, Strahlentherapie und Onkologie.

[9]  N. Willich,et al.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  T. Wiegel,et al.  Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study. , 2009, International journal of radiation oncology, biology, physics.

[11]  E. Messing,et al.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.

[12]  Kara Hamilton,et al.  Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[13]  M. Kattan,et al.  Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. , 2005, The Journal of urology.

[14]  T. Wiegel,et al.  Adjuvant radiotherapy after radical prostatectomy , 2007 .

[15]  Richard K Valicenti,et al.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  T. Wiegel,et al.  Adjuvant Radiotherapy after Radical Prostatectomy: Indications, Results and Side Effects , 2007, Urologia Internationalis.

[17]  E. Sacco,et al.  Clinical and Pathological Characteristics of Patients Presenting with Biochemical Progression after Radical Retropubic Prostatectomy for Pathologically Organ-Confined Prostate Cancer , 2006, Urologia Internationalis.

[18]  A. Haese*,et al.  Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer , 2006, World Journal of Urology.

[19]  W. Catalona,et al.  Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates. , 2005, The Journal of urology.

[20]  M. Piérart,et al.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.

[21]  E. Bergstralh,et al.  Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. , 2004, The Journal of urology.

[22]  William J Catalona,et al.  Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. , 2004, The Journal of urology.

[23]  E. B. Butler,et al.  Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. , 2004, JAMA.

[24]  S. Schild,et al.  Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. , 2003, The Journal of urology.

[25]  A. Zietman,et al.  Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Zietman,et al.  Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors. , 2002, Urology.

[27]  D W Hillman,et al.  Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. , 2000, The Journal of urology.

[28]  M S Anscher,et al.  Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. , 2000, International journal of radiation oncology, biology, physics.

[29]  D. Grignon,et al.  Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage. , 1999, Urology.

[30]  A. Zietman,et al.  Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[31]  S. Schild,et al.  The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. , 1996, The Journal of urology.

[32]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .